Literature DB >> 2546339

Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to bovine virus diarrhoea virus in milk.

R Niskanen, S Alenius, B Larsson, N Juntti.   

Abstract

The present study shows that milk is an appropriate source for detection of seroreactors to bovine virus diarrhoea virus (BVDV). There was close agreement between antibody titres in serum and in skim milk, as determined by an indirect enzyme-linked immunosorbent assay. The antibody titres were usually lower in skim milk than in serum, but all seropositive cows (n = 84) were also skim milk-positive and all but one seronegative cow (n = 55) proved negative in skim milk. During lactation, the level of antibodies to BVDV in milk showed an inverse relationship to the amount of milk produced. However, there was a sufficient level of antibodies in milk throughout lactation to permit an adequate determination of BVDV antibody status in dairy cows. There was a mutual good agreement between milk antibody titre in the four mammary quarters, irrespective of milk cell count. Milk can be used to detect seroreactors to BVDV. Milk is preferable to blood in large-scale epidemiological studies, since the sampling procedure is much simpler.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546339     DOI: 10.1111/j.1439-0450.1989.tb00576.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  11 in total

1.  Bovine virus diarrhoea virus in semen from acutely infected bulls.

Authors:  E Kommisrud; T Vatn; J R Lang-Ree; T Løken
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

2.  Detection of bovine herpesvirus 1 glycoprotein E antibodies in individual milk samples by enzyme-linked immunosorbent assays.

Authors:  G J Wellenberg; E R Verstraten; M H Mars; J T Van Oirschot
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  The duration of antibodies against bovine virus diarrhoea virus in bulk milk.

Authors:  B Fredriksen; T Løken; S A Odegaard
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

4.  The effect of bovine virus diarrhoea virus on reproduction in recently infected Norwegian dairy herds.

Authors:  B Fredriksen; S A Odegaard; T Løken
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

5.  An experimental study of a concurrent primary infection with bovine respiratory syncytial virus (BRSV) and bovine viral diarrhoea virus (BVDV) in calves.

Authors:  M Elvander; C Baule; M Persson; L Egyed; A Ballagi-Pordány; S Belák; S Alenius
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

6.  Prevalence of Bovine Viral Diarrhoea Virus antibodies among the industrial dairy cattle herds in suburb of Mashhad-Iran.

Authors:  M Talebkhan Garoussi; A Haghparast; M R Hajenejad
Journal:  Trop Anim Health Prod       Date:  2008-10-08       Impact factor: 1.559

7.  Challenges for bovine viral diarrhoea virus antibody detection in bulk milk by antibody enzyme-linked immunosorbent assays due to changes in milk production levels.

Authors:  Alessandro Foddai; Claes Enøe; Anders Stockmarr; Kaspar Krogh; Åse Uttenthal
Journal:  Acta Vet Scand       Date:  2015-06-23       Impact factor: 1.695

8.  Evaluation of temporal surveillance system sensitivity and freedom from bovine viral diarrhea in Danish dairy herds using scenario tree modelling.

Authors:  Alessandro Foddai; Anders Stockmarr; Anette Boklund
Journal:  BMC Vet Res       Date:  2016-06-21       Impact factor: 2.741

9.  Seroprevalence of bovine viral diarrhea virus in crossbred dairy cattle in Bangladesh.

Authors:  Mohammed Arif Uddin; A S M Lutful Ahasan; Kamrul Islam; Md Zohorul Islam; Altaf Mahmood; Ariful Islam; Kazi Muhammad Fakhrul Islam; Abdul Ahad
Journal:  Vet World       Date:  2017-08-12

10.  Bovine viral diarrhoea virus seroprevalence and vaccination usage in dairy and beef herds in the Republic of Ireland.

Authors:  D J Bosco Cowley; Tracy A Clegg; Michael L Doherty; Simon J More
Journal:  Ir Vet J       Date:  2012-07-31       Impact factor: 2.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.